Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Alogabat with Itraconazole
NCT03774576Phase 1Completed
- Sponsor
- Roche
- Start
- Dec 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of alogabat in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Roche. Primary endpoint: Maximum Concentration of RO7017773 in Plasma. Started Dec 2018; status: completed.
02
Drugs
alogabat
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03774576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774576.